​​​​​​​Ex-Turing Pharma CEO Martin Shkreli can’t get away from his bad rep.

Pharma watchdog Elijah Cummings blasted Trump on Thursday for what he said was a made-up story.

Stada already had two interested buyers in the mix as of earlier this week. And now, it’s got three.

President Trump told Robert Kennedy Jr. he won't "back down" from plans to create vax safety commission, despite guaranteed "uproar"…

It’s no secret that Sanofi has struggled of late at the dealmaking table. But why? The deal prospectus from former target Actelion buyer J&J offers some…

As activist investor William Ackman, a thorn in Zoetis' side for two years, reported that he'd sold off his stake, the animal health giant reported…

A new head-to-head study pitting Pfizer's Xeljanz against AbbVie behemoth Humira isn't going to help Pfizer as much as it had hoped.

Americans could import certain meds from Canada if a bipartisan group of senators get their way.

Will Valeant price its new psoriasis med at a discount to rivals to reflect its hefty suicide risk-management program? And if not, can it still compete?…